Please provide your email address to receive an email when new articles are posted on . Adbry is now available in the U.S. as a 300 mg/2 mL single-dose autoinjector for adults with atopic dermatitis.

Please provide your email address to receive an email when new articles are posted on . Adbry is approved for moderate to severe atopic dermatitis. The autoinjector delivers a single 300 mg/mL dose.

The Adbry autoinjector is for use in adults only. A new single-dose autoinjector presentation of Adbry ® (tralokinumab-ldrm) is now available for use in the treatment of moderate to severe atopic ...